tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

HCM Stock Latest News

Hutchmed says NDA for Tazverik granted conditional approval in China
The FlyHutchmed says NDA for Tazverik granted conditional approval in China
12d ago
HCM
HUTCHMED’s Strong Financial Performance and Strategic Growth Drive Buy Rating
PremiumRatings
HUTCHMED’s Strong Financial Performance and Strategic Growth Drive Buy Rating
12d ago
HCM
Hutchmed Reports Strong 2024 Growth and Profitability
PremiumCompany Announcements
Hutchmed Reports Strong 2024 Growth and Profitability
14d ago
HCM
Hutchmed sees FY25 Oncology/Immunology revenue $350M-$450M
PremiumThe Fly
Hutchmed sees FY25 Oncology/Immunology revenue $350M-$450M
14d ago
HCM
Hutchmed reports FY24 EPS 22c vs. 59c last year
PremiumThe Fly
Hutchmed reports FY24 EPS 22c vs. 59c last year
14d ago
HCM
Hutchmed/Innovent update on Phase 2/3 study of Fruquintinib+Sintilimab
PremiumThe FlyHutchmed/Innovent update on Phase 2/3 study of Fruquintinib+Sintilimab
15d ago
HCM
Hutchmed completes enrollment of fanregratinib trial
Premium
The Fly
Hutchmed completes enrollment of fanregratinib trial
27d ago
HCM
HUTCHMED Updates on Major Divestment in Shanghai Hutchison Pharmaceuticals
Premium
Company Announcements
HUTCHMED Updates on Major Divestment in Shanghai Hutchison Pharmaceuticals
1M ago
6K
HCM
Hutchmed price target raised to $27 from $26 at BofA
PremiumThe Fly
Hutchmed price target raised to $27 from $26 at BofA
2M ago
HCM
Hutchmed announces NMPA approval for Orpathys supplemental new drug application
PremiumThe Fly
Hutchmed announces NMPA approval for Orpathys supplemental new drug application
3M ago
HCM
Hutchmed price target lowered to $26 from $30 at BofA
PremiumThe Fly
Hutchmed price target lowered to $26 from $30 at BofA
3M ago
HCM
Morning Movers: Neumora Therapeutics plummets after KOASTAL-1 misses endpoint
PremiumThe Fly
Morning Movers: Neumora Therapeutics plummets after KOASTAL-1 misses endpoint
3M ago
HCM
MCD
Hutchmed announces NDA acceptance in China, payment from AstraZeneca
PremiumThe FlyHutchmed announces NDA acceptance in China, payment from AstraZeneca
3M ago
AZN
HCM
Hutchmed divests 45% interest in Shanghai Hutchison for $608M
Premium
The Fly
Hutchmed divests 45% interest in Shanghai Hutchison for $608M
3M ago
HCM
Hutchmed to receive milestone payment from Takeda
Premium
The Fly
Hutchmed to receive milestone payment from Takeda
4M ago
HCM
TAK
Hutchmed announces BTD in China for Orpathys, Tagrisso combination
PremiumThe Fly
Hutchmed announces BTD in China for Orpathys, Tagrisso combination
4M ago
HCM
Hutchmed announces Elunate, Tyvyt NDA granted approval in China
PremiumThe Fly
Hutchmed announces Elunate, Tyvyt NDA granted approval in China
4M ago
HCM
Hutchmed to receive milestone payment following Takeda launch of Fruzaqla
PremiumThe Fly
Hutchmed to receive milestone payment following Takeda launch of Fruzaqla
4M ago
HCM
TAK
Hutchmed announces new, updated data from sovleplenib ESLIM-01 trial
PremiumThe Fly
Hutchmed announces new, updated data from sovleplenib ESLIM-01 trial
5M ago
HCM
Hutchmed to receive $20M milestone payment from Takeda for Fruzaqla sales
PremiumThe FlyHutchmed to receive $20M milestone payment from Takeda for Fruzaqla sales
5M ago
HCM
TAK
Hutchmed announces results from SAVANNAH trial
Premium
The Fly
Hutchmed announces results from SAVANNAH trial
6M ago
AZN
HCM
Hutchmed, Takeda receive Japan MHLW approval to manufacture and market Fruzaqla
Premium
The Fly
Hutchmed, Takeda receive Japan MHLW approval to manufacture and market Fruzaqla
6M ago
HCM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >